Pharmaresearch Co., Ltd. logo

Pharmaresearch Co., Ltd. (214450)

Market Closed
10 Aug, 06:30
KOSDAQ KOSDAQ
410,000. 00
+31,500
+8.3223%
2.98T Market Cap
- P/E Ratio
950% Div Yield
243,465 Volume
9,117.91 Eps
378,500
Previous Close
Add Transaction
Day Range
377,500 412,000
Year Range
233,500 713,000
Want to track 214450 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

214450 closed today higher at ₩410,000, an increase of 8.3223% from yesterday's close, completing a monthly decrease of -4.6512% or -₩20,000. Over the past 12 months, 214450 stock lost -4.6512%.
214450 is not paying dividends to its shareholders.
The last earnings report, released on Nov 11, 2025, exceeded the consensus estimates by 4,234.3881%. On average, the company has surpassed earnings expectations by 1,411.4627%, based on the last three reports.
Pharmaresearch Co., Ltd. has completed 1 stock splits, with the recent split occurring on Oct 30, 2025.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on KOSDAQ (KRW).

214450 Chart

People also search for

HLB Inc.
40,700
+9.1153%
St Pharm Co., Ltd.
108,000
+7.8921%
Mezzion Pharma Co., Ltd.
60,700
+11.3761%
Hyundai Bioscience Co., Ltd.
7,410
+9.1311%
Chabiotech Co., Ltd.
9,850
+5.914%

Pharmaresearch Co., Ltd. (214450) FAQ

What is the stock price today?

The current price is ₩410,000.00.

On which exchange is it traded?

Pharmaresearch Co., Ltd. is listed on KOSDAQ.

What is its stock symbol?

The ticker symbol is 214450.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 950%.

What is its market cap?

As of today, the market cap is 2.98T.

Has Pharmaresearch Co., Ltd. ever had a stock split?

Pharmaresearch Co., Ltd. had 1 splits and the recent split was on Oct 30, 2025.

Pharmaresearch Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Sang-Soo Jung CEO
KOSDAQ Exchange
KR7214450009 ISIN
KR Country
496 Employees
- Last Dividend
30 Oct 2025 Last Split
- IPO Date

Overview

PharmaResearch Co., Ltd., a prominent biopharmaceutical company established in 1993, plays a significant role in the South Korean pharmaceutical landscape. Previously known as Pharma Research Products Co., Ltd., the company underwent a name change to PharmaResearch Co., Ltd. in April 2021. The company's operations span across a wide array of pharmaceutical products and services, focusing primarily on the development, production, and distribution of medical devices, injections, eye drops, and skin care products, alongside engaging in the functional foods sector. Their commitment extends to offering cutting-edge solutions for tissue regeneration, wound healing, skincare, and more. Furthermore, PharmaResearch Co., Ltd. is also involved in software development and consulting, showcasing a versatile approach toward healthcare and biotechnology.

Products and Services

  • Re-An eye drops: Designed to protect eyes from corneal damages caused by various factors, ensuring eye health and safety.
  • JBP PLAMON injection: A brown ampoule containing a pale yellow transparent liquid, utilized for specialized treatments.
  • ZADAXIN injection: Serves as adjunctive therapy for influenza vaccination, particularly beneficial for immunocompromised elderly patients.
  • PLACENTEX injection: Aims at treating and restoring tissue in wounds, promoting healing and recovery.
  • CLEVIEL VOLUME: A dermal filler used to temporarily improve facial wrinkles in adults, enhancing physical appearance through physical restoration.
  • Rejuran HB plus: Used for the temporary improvement of crow’s feet wrinkles in adults, offering cosmetic enhancement.
  • Rejuvenex injection: Acts as a tissue regeneration activator, regenerating connective tissues, including ligament, tendon, skin, etc., for therapeutic benefits.
  • Rejuvenex cream: Facilitates wound healing through rapid tissue regeneration, improving skin condition.
  • REJURAN series (various products): Encompasses medical devices and skincare products for the face, neck, hands, etc., geared towards skin protection and rejuvenation.
  • D+CELL 350 TRA I, concentrated rejuvenation cream, intensive repair serum, activating facial toner, high potency eye lift, moisture balancer, mask, hair cream, and hydro products: This comprehensive range offers skin and hair care solutions, promoting overall aesthetic and health improvements.
  • REJURAN tone-up booster, REJURAN FORTE, and CONJURAN medical devices: Additional offerings in the REJURAN line, focused on skin tone enhancement, intensive skin restoration, and medical treatment of skin issues.

PharmaResearch Co., Ltd. not only provides an extensive portfolio of healthcare products but is also dedicated to innovation through its involvement in functional foods and technology sectors such as software development and consulting. This diverse range of products and services highlights the company's commitment to improving health, wellness, and beauty across multiple fronts.

Contact Information

Address: 77-19, Gwahakdanji-ro, Gangneung-si, South Korea, 25452
Phone: 82 33 645 7640